These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 7027655)

  • 1. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
    Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of clobetasol dipropionate and betamethasone dipropionate].
    Rozzoni M; Tribbia G; Reseghetti A; Bassi R
    G Ital Dermatol Venereol; 1982; 117(5):LXV-LXIX. PubMed ID: 6764916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
    Rozman TA; Wiedey KD; Renovanz HD
    Z Hautkr; 1983 Mar; 58(6):398-409. PubMed ID: 6342288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of clobetasol 17-propionate and traimcinolone acetonide].
    Esser B
    Z Hautkr; 1979 Oct; 54(20):893-7. PubMed ID: 392970
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
    Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
    Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
    [No Abstract]   [Full Text] [Related]  

  • 7. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K
    Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment.
    Wendt H; Mugglestone CJ; Wiseman RA
    Br J Dermatol; 1978 Oct; 99(4):411-6. PubMed ID: 361059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
    Blum G; Kröpfli P; Küng D; Suter H
    Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients.
    Keczkes K; Teasdale P; Wiseman RA; Mugglestone CJ
    Br J Dermatol; 1978 Oct; 99(4):417-20. PubMed ID: 361060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB.
    Larkö O; Swanbeck G; Svartholm H
    Acta Derm Venereol; 1984; 64(2):151-4. PubMed ID: 6203304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A test of the half-side comparative design in the clinical evaluation of topical steroids, using diflucortolone and betamethasone creams.
    August PJ; Platt NE; Wiseman RA
    Br J Clin Pract; 1985 Oct; 39(10):383-7. PubMed ID: 3907679
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophic skin striae following the use of clobetasol propionate ointment.
    Hardie RA; Waring AJ; Barnetson RS
    Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
    [No Abstract]   [Full Text] [Related]  

  • 18. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
    Geraldez CB; Gutierrez GT
    Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two application schedules for clobetasol 17 propionate.
    vd Harst LC; de Jonge H; Pot F; Polano MK
    Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.